Spironolactone

Product NDC
70518-3721
11-digit product format
705183721
Labeler code
70518
Product ID
70518-3721_4f80edc6-df4e-bc19-e063-6294a90ada37
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Spironolactone
Dosage form
TABLET, COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA040750
Marketing category
ANDA
Marketing start
2023-04-24
Substance
SPIRONOLACTONE
Active strength
100 mg/1
Pharmacologic classes
Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage70518-372170518-3721-1DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A040750-001SPIRONOLACTONESPIRONOLACTONE25MGTABLET / ORALAB2006-08-29
A040750-002SPIRONOLACTONESPIRONOLACTONE50MGTABLET / ORALAB2006-08-29
A040750-003SPIRONOLACTONESPIRONOLACTONE100MGTABLET / ORALAB2006-08-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A040750-001AB
A040750-002AB
A040750-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A040750-001SPIRONOLACTONE25MGTABLET / ORALAB2006-08-29a50c72e98297…
2026-08-01 22:54:322026-06A040750-002SPIRONOLACTONE50MGTABLET / ORALAB2006-08-29a50c72e98297…
2026-08-01 22:54:322026-06A040750-003SPIRONOLACTONE100MGTABLET / ORALAB2006-08-29a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A040750-001AB1a50c72e98297…
2026-08-01 22:54:322026-06A040750-002AB1a50c72e98297…
2026-08-01 22:54:322026-06A040750-003AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 2 · 28 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SpironolactoneSPIRONOLACTONEPD-Rx Pharmaceuticals, Inc.73564b3d-8ede-4008-b75c-1277153b5bb62026-07-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEPD-Rx Pharmaceuticals, Inc.8a66d90e-5450-4716-8c01-e7dc1967d00d2026-07-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEPD-Rx Pharmaceuticals, Inc.8cbe2215-744c-438a-b3d6-b7d6ae7692312026-07-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEREMEDYREPACK INC.8f0291a9-c8a6-4298-a540-23abc01fae092026-07-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONECoupler LLC56050192-c499-64bd-e063-6294a90acbeb2026-07-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONECoupler LLC53454970-2c0f-54c3-e063-6294a90aac0a2026-06-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEREMEDYREPACK INC.b119ed8a-289a-46c5-9778-6b07e4c061c42026-06-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEProficient Rx LP6782c1c1-d1ac-4c07-b7cb-a74699d2f9fe2026-05-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEREMEDYREPACK INC.7646ca22-710e-4a5c-9613-b829e2f9d5ce2026-04-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
ndc (product): 70518-3721
SpironolactoneSPIRONOLACTONEProficient Rx LP6867776e-b4fd-41db-8da8-a5af76eed2802026-04-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEDirect_Rxffd2f3f5-c7c8-0028-e053-6394a90aaf172026-03-05Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONENuCare Pharmaceuticals,Inc.4b9a20c4-46f2-d572-e063-6294a90a30ad2026-02-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONENuCare Pharmaceuticals, Inc.4b4af7e0-f35b-9bf6-e063-6294a90a83b92026-02-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEOxford Pharmaceuticals, LLC852684dc-e1c6-4caa-bccb-10ac90bbb3bb2026-02-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONECoupler LLC472ee2ad-7e57-bef1-e063-6394a90a02062025-12-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEA-S Medication Solutionsbb29ea6f-c294-4895-9e9b-544d69651a352025-12-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEA-S Medication Solutionsc328f555-2da8-43ac-bc04-0e89d4d2aa532025-12-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEA-S Medication Solutionscd64e343-e15e-43b1-88b5-a3d5ba23fedf2025-11-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEA-S Medication Solutions08738ad4-1607-4d55-af71-6790477353bd2025-11-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750
SpironolactoneSPIRONOLACTONEPreferred Pharmaceuticals Inc.5e456f3c-f93e-41c6-80c5-a737ed70feda2025-09-24Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040750
application number: ANDA040750

Additional Listing Data#

Finished product
Yes
Brand name base
Spironolactone
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SPIRONOLACTONE100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
27O7W4T232Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
198222Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
7646ca22-710e-4a5c-9613-b829e2f9d5ceAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d335cba1-5b36-51c8-120a-594ec9d05330Product name520251114
25f5e2cf-3572-477b-994c-aa692751e5a8Product name220250616
f151007d-265d-9fbe-857d-1d44f1cb76baProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-3721-0Spironolactone30 in 1 BLISTER PACKTABLET, COATED308
70518-3721-1Spironolactone90 in 1 BOTTLE, PLASTICTABLET, COATED908
70518-3721-2Spironolactone30 in 1 BOTTLE, PLASTICTABLET, COATED308
70518-3721-3Spironolactone100 in 1 BOXTABLET, COATED1008
70518-3721-4Spironolactone1 in 1 POUCHTABLET, COATED18

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-3721SPIRONOLACTONE TABLET, COATED [REMEDYREPACK INC.]4Current NDC, 5 package rows20241127_7646ca22-710e-4a5c-9613-b829e2f9d5ce.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
198222spironolactone 100 MG Oral TabletPSN7646ca22-710e-4a5c-9613-b829e2f9d5ce8
198222spironolactone 100 MG Oral TabletSCD7646ca22-710e-4a5c-9613-b829e2f9d5ce8

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70518-3721-07051837210030 TABLET, COATED in 1 BLISTER PACK (70518-3721-0) 2023-04-24NoNoCurrent
70518-3721-17051837210190 in 1 BOTTLE, PLASTICHistorical
70518-3721-27051837210230 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-3721-2) 2025-08-27NoNoCurrent
70518-3721-370518372103100 POUCH in 1 BOX (70518-3721-3) / 1 TABLET, COATED in 1 POUCH (70518-3721-4) 100 pouch2026-01-28NoNoCurrent
70518-3721-4705183721041 in 1 POUCHHistorical